Pharmacokinetic studies in rats demonstrated an oral bioavailability of 38.4%, with a mean Cmax of 2,252 ng/mL and terminal elimination half-lives of 3.80 1.10 hours (IV) and 6.90 1.20 hours (oral) (Awosemo et al., 2021)
Notably, known clinical risk factors for acute pancreatitis including alcohol use, prior history of acute pancreatitis, and gallstone disease were not associated with an increased risk of acute pancreatitis after GLP-1RA initiation in this study
High levels of IGF-1 can trigger the bodys negative feedback loop, potentially suppressing natural GH release over time
GLP-1 stimulates insulin secretion when blood glucose levels are elevated, suppresses glucagon release (which reduces glucose production by the liver), slows gastric emptying, and promotes satiety through effects on appetite centres in the brain
Train longer and harder with a formula designed to delay fatigue